JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB84028

Anti-FABP5 antibody

0

(1 Review)

|

(9 Publications)

Rabbit Polyclonal FABP5 antibody. Suitable for IP, WB, ICC/IF and reacts with Human samples. Cited in 9 publications.

View Alternative Names

Fatty acid-binding protein 5, Epidermal-type fatty acid-binding protein, Psoriasis-associated fatty acid-binding protein homolog, E-FABP, PA-FABP, FABP5

4 Images
Immunocytochemistry/ Immunofluorescence - Anti-FABP5 antibody (AB84028)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-FABP5 antibody (AB84028)

ICC/IF image of ab84028 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal Goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab84028, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 Goat anti-Rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 4% PFA fixed (10 min) Hek293, HepG2, MCF-7 cells at 5µg/ml, and in 100% Methanol fixed (5 min) HeLa, Hek293, HepG2, MCF-7 cells at 5µg/ml.

Immunoprecipitation - Anti-FABP5 antibody (AB84028)
  • IP

Lab

Immunoprecipitation - Anti-FABP5 antibody (AB84028)

FABP5 was immunoprecipitated using 0.5mg A431 whole cell extract, 5μg of Rabbit polyclonal to and 50μl of protein G magnetic beads (+). No antibody was added to the control (-).

The antibody was incubated under agitation with Protein G beads for 10min, A431 whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.

Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70°C; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab84028.

Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).

Band : 16kDa; FABP5.

All lanes:

Immunoprecipitation - Anti-FABP5 antibody (ab84028)

Predicted band size: 15 kDa

true

Exposure time: 20min

Western blot - Anti-FABP5 antibody (AB84028)
  • WB

Unknown

Western blot - Anti-FABP5 antibody (AB84028)

Lanes 1-3 : Merged signal (red and green). Green - ab84028 observed at 17 kDa. Red - loading control ab8245 observed at 36 kDa.

ab84028 Anti-FABP5 antibody was shown to specifically react with FABP5 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265905 (knockout cell lysate ab257431) was used. Wild-type and FABP5 knockout samples were subjected to SDS-PAGE. ab84028 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2. 5 hours at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-FABP5 antibody (ab84028) at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

FABP5 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human FABP5 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-fabp5-knockout-hela-cell-line-ab265905'>ab265905</a>)

Lane 3:

PC-3 cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 15 kDa

Observed band size: 17 kDa

false

Western blot - Anti-FABP5 antibody (AB84028)
  • WB

Unknown

Western blot - Anti-FABP5 antibody (AB84028)

All lanes:

Western blot - Anti-FABP5 antibody (ab84028) at 1 µg/mL

Lane 1:

Human skin tissue lysate - total protein (<a href='/en-us/products/unavailable/human-skin-tissue-lysate-total-protein-ab30166'>ab30166</a>) at 10 µg

Lane 2:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 3:

A431 (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 4:

HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 15 kDa

Observed band size: 16 kDa

true

Exposure time: 3min

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "5 µg/mL", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Cow": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Pig": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Sheep": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The FABP5 protein also known as Fatty Acid Binding Protein 5 or Epidermal-type Fatty Acid Binding Protein (E-FABP) serves an important role in the transport and metabolism of long-chain fatty acids. It has a molecular mass of approximately 15 kDa. FABP5 is expressed in multiple tissues with notably high expression in the epidermis brain liver and adipose tissue. This protein assists in intracellular fatty acid movement affecting cellular lipid catabolism.
Biological function summary

FABP5 interacts with specific ligands such as long-chain fatty acids which influences cellular processes like growth differentiation and energy homeostasis. It is not known to be part of a larger complex. This protein is integral in regulating lipid signaling pathways and responses due to its binding capacity which modulates the availability of fatty acids for metabolic processes. Its expression pattern hints at a possible role in the body's adaptation to dietary lipid intake.

Pathways

FABP5 holds a significant position in the peroxisome proliferator-activated receptor (PPAR) signaling pathway and the fatty acid metabolism pathway. In the PPAR signaling pathway FABP5 influences the activity of PPARβ/δ receptors which regulate gene expression involved in lipid metabolism and energy homeostasis. It is related to other fatty acid binding proteins such as FABP4 which similarly participate in lipid metabolic processes and have roles in the regulation of lipid and glucose metabolism.

Researchers have linked FABP5 to conditions like psoriasis and type 2 diabetes. In psoriasis the overexpression of FABP5 has been observed in skin lesions suggesting that it might contribute to the pathological process. FABP5 is also connected to metabolic syndrome and insulin resistance as its dysregulation can influence lipid and glucose metabolism processes. In these disorders FABP5 interacts with proteins like PPARγ indicating possible intervention points for therapeutic targeting.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Intracellular carrier for long-chain fatty acids and related active lipids, such as endocannabinoids, that regulate the metabolism and actions of the ligands they bind. In addition to the cytosolic transport, selectively delivers specific fatty acids from the cytosol to the nucleus, wherein they activate nuclear receptors (PubMed : 21395585, PubMed : 22170058). Delivers retinoic acid to the nuclear receptor peroxisome proliferator-activated receptor delta; which promotes proliferation and survival. May also serve as a synaptic carrier of endocannabinoid at central synapses and thus controls retrograde endocannabinoid signaling. Modulates inflammation by regulating PTGES induction via NF-kappa-B activation, and prostaglandin E2 (PGE2) biosynthesis during inflammation (By similarity). May be involved in keratinocyte differentiation (PubMed : 8092987).
See full target information FABP5

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 14:125 PubMed36792587

2023

NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via mC methylation.

Applications

Unspecified application

Species

Unspecified reactive species

Min Yang,Renxiong Wei,Sheng Zhang,Sang Hu,Xiaoxiao Liang,Zhiqiang Yang,Chong Zhang,Yufeng Zhang,Lin Cai,Yuanlong Xie

Cancer biology & therapy 23:424-438 PubMed35816613

2022

Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein.

Applications

Unspecified application

Species

Unspecified reactive species

Yanping Tang,Kezhi Li,Bangli Hu,Zhengmin Cai,Jilin Li,Hao Tao,Ji Cao

Biochemical genetics 59:1648-1665 PubMed34050452

2021

CircARL8B Contributes to the Development of Breast Cancer Via Regulating miR-653-5p/HMGA2 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Hansheng Wu,Jingyun Xu,Guoliang Gong,Yuanxin Zhang,Shenggui Wu

Journal of cellular and molecular medicine 25:4487-4500 PubMed33837625

2021

FABP5 enhances malignancies of lower-grade gliomas via canonical activation of NF-κB signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Yichang Wang,Alafate Wahafu,Wei Wu,Jianyang Xiang,Longwei Huo,Xudong Ma,Ning Wang,Hao Liu,Xiaobin Bai,Dongze Xu,Wanfu Xie,Maode Wang,Jia Wang

Nature communications 11:2768 PubMed32488016

2020

Cellular census of human fibrosis defines functionally distinct stromal cell types and states.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas B Layton,Lynn Williams,Fiona McCann,Mingjun Zhang,Marco Fritzsche,Huw Colin-York,Marisa Cabrita,Michael T H Ng,Marc Feldmann,Stephen N Sansom,Dominic Furniss,Weilin Xie,Jagdeep Nanchahal

Cancer management and research 10:6275-6284 PubMed30538573

2018

Altered epidermal fatty acid-binding protein expression in hepatocellular carcinoma predicts unfavorable outcomes.

Applications

Unspecified application

Species

Unspecified reactive species

Jia-Bin Lu,Shao-Hang Cai,Ying-Hua Pan,Jing-Ping Yun

Proteome science 16:14 PubMed30061793

2018

Comparative iTRAQ proteomics revealed proteins associated with horn development in yak.

Applications

Unspecified application

Species

Unspecified reactive species

Mingna Li,Xiaoyun Wu,Xian Guo,Pengjia Bao,Xuezhi Ding,Min Chu,Chunnian Liang,Ping Yan

International journal of oncology 52:787-803 PubMed29328367

2018

Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.

Applications

Unspecified application

Species

Unspecified reactive species

Hayat Zaatiti,Jad Abdallah,Zeina Nasr,George Khazen,Anthony Sandler,Tamara J Abou-Antoun

PloS one 10:e0127003 PubMed26020772

2015

Level of Fatty Acid Binding Protein 5 (FABP5) Is Increased in Sputum of Allergic Asthmatics and Links to Airway Remodeling and Inflammation.

Applications

Unspecified application

Species

Unspecified reactive species

Hille Suojalehto,Pia Kinaret,Maritta Kilpeläinen,Elina Toskala,Niina Ahonen,Henrik Wolff,Harri Alenius,Anne Puustinen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com